7 patents
Utility
Crystalline Forms of a TYK2 Inhibitor
11 Jan 24
Described herein are crystalline forms of 1-(5-((7-fluoro-2,3-dihydrobenzo[b][1,4]dioxin-5-yl)amino)-7-(methylamino)pyrazolo[1,5-a]pyrimidin-3-yl)-3-((1R,2S)-2-fluorocyclopropyl)urea adipate, and solvates thereof.
John NUSS, Venkat BOLLU, Shendong YUAN
Filed: 5 Jul 23
Utility
TYK2 Pseudokinase Ligands
21 Dec 23
Described herein are TYK2 pseudokinase ligands and methods of utilizing TYK2 pseudokinase ligands in the treatment of diseases, disorders or conditions.
Raju MOHAN, John NUSS, Jason HARRIS, Shendong YUAN
Filed: 28 Aug 23
Utility
TYK2 Pseudokinase Ligands
2 Nov 23
Described herein are TYK2 pseudokinase ligands and methods of utilizing TYK2 pseudokinase ligands in the treatment of diseases, disorders or conditions.
Raju MOHAN, John NUSS, Jason HARRIS, Shendong YUAN
Filed: 6 Jul 23
Utility
NLRP3 Modulators
21 Sep 23
Described herein are NLRP3 modulators and methods of utilizing NLRP3 modulators in the treatment of diseases, disorders or conditions.
James COLLINS, Venkat BOLLU, Shendong YUAN, John NUSS
Filed: 14 Mar 23
Utility
TYK2 Pseudokinase Ligands
2 Jun 22
Described herein are TYK2 pseudokinase ligands and methods of utilizing TYK2 pseudokinase ligands in the treatment of diseases, disorders or conditions.
Raju MOHAN, John NUSS, Jason HARRIS, Shendong YUAN
Filed: 25 Mar 20
Utility
TYK2 Pseudokinase Ligands
5 May 22
Described herein are TYK2 pseudokinase ligands and methods of utilizing TYK2 pseudokinase ligands in the treatment of diseases, disorders or conditions.
Raju MOHAN, John NUSS, Jason HARRIS, Shendong YUAN
Filed: 7 Feb 20
Utility
TYK2 Pseudokinase Ligands
13 May 21
Described herein are TYK2 pseudokinase ligands and methods of utilizing TYK2 pseudokinase ligands in the treatment of diseases, disorders or conditions.
Raju MOHAN, John NUSS, Jason HARRIS, Shendong YUAN
Filed: 5 Nov 20
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first